 Fauquier ENT News
For decades, treatment for obstructive sleep apnea (OSA) has mostly centered around CPAP machines, oral appliances, surgery, and weight loss. But a new investigational medication from Apnimed is generating major interest because it may become one of the first effective oral medications for sleep apnea.The drug, called AD109, has now completed large Phase 3 clinical trials with encouraging results.
What Is AD109? AD109 is a once-nightly pill designed to help keep the airway open during sleep. Rather than acting like a sedative, the medication works by increasing upper-airway muscle tone to reduce airway collapse. The pill combines two medications: - Atomoxetine – 75 mg
- Aroxybutynin – 2.5 mg
Earlier studies also tested a higher 5 mg dose of... Continue Reading » 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
